STAT3 has been targeted in HNSCC xenograft models using the small-molecule, STAT3 inhibitor, Stattic, which was shown to enhance IR-sensitivity [19, 24]. This evidence concerns the gene STAT3 and head and neck squamous cell carcinoma.